In one paragraphArticle in Journal of natural products, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Alison Batista da SilvaDepartamento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Fortaleza, Ceará 60.021-970, Brazil.
Francisco Chagas L PintoDepartamento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Fortaleza, Ceará 60.021-970, Brazil.
Edilberto R SilveiraDepartamento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Fortaleza, Ceará 60.021-970, Brazil.
Tercio de Freitas PauloDepartamento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Fortaleza, Ceará 60.021-970, Brazil.ORCID 0000-0001-6815-7547 Diego V WilkeNúcleo de Pesquisa e Desenvolvimento de Medicamentos, Universidade Federal do Ceará, Fortaleza, Ceará 60.430-275, Brazil.
Elthon G FerreiraNúcleo de Pesquisa e Desenvolvimento de Medicamentos, Universidade Federal do Ceará, Fortaleza, Ceará 60.430-275, Brazil.ORCID 0000-0001-8381-7849 Leticia V Costa-LotufoDepartamento de Farmacologia, Universidade de São Paulo, São Paulo, São Paulo 05508-900, Brazil.ORCID 0000-0003-1861-5153 José Delano Barreto Marinho-FilhoNúcleo de Pesquisa e Pós-graduação, Universidade Federal do Delta do Parnaíba, Parnaíba, Piauí 64202-020, Brazil.ORCID 0000-0002-2493-6159 Ayslan B BarrosNúcleo de Pesquisa e Pós-graduação, Universidade Federal do Delta do Parnaíba, Parnaíba, Piauí 64202-020, Brazil.
Genoveffa NuzzoCNR, Istituto di Chimica Biomolecolare, Bio-Organic Chemistry Unit, Pozzuoli, Naples 80078, Italy.ORCID 0000-0001-7065-2379 Angelo FontanaCNR, Istituto di Chimica Biomolecolare, Bio-Organic Chemistry Unit, Pozzuoli, Naples 80078, Italy.ORCID 0000-0002-5453-461X Norberto Kássio V MonteiroDepartamento de Química Analítica e Físico-Química, Universidade Federal do Ceará, Fortaleza, Ceará 60020-181, Brazil.ORCID 0000-0002-5847-5733 Otilia D L PessoaDepartamento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Fortaleza, Ceará 60.021-970, Brazil.ORCID 0000-0002-1617-7586 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Five new rifamycin derivatives, named salinirifamycins A-E (
Indexed as
ActinobacteriaAnti-Bacterial AgentsMicromonosporaceaeRifamycinsBrazilEnterococcus faecalisMicrobial Sensitivity TestsMolecular StructureStaphylococcus aureusAnti-Bacterial AgentsRifamycins
Identifiers
PMID41478838
PMCPMC12836363
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390